Korin Harding, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5 Walker St, Suite 1, Lenox, MA 01240 Phone: 413-637-4700 Fax: 413-637-0366 |
Dr. Kathryn Finch Mckinney, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 481 Pittsfield Rd, Lenox, MA 01240 Phone: 413-499-3430 |
Jacob W Tetrault, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5 Walker St Ste 1, Lenox, MA 01240 Phone: 413-637-4700 Fax: 413-637-0366 |
Dr. Manami Eiki, PH.D., R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 489 Pittsfield Lenox Rd, Lenox, MA 01240 Phone: 413-499-3141 |
Ridge Joseph Sulkey Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 481 Pittsfield Rd, Lenox, MA 01240 Phone: 413-499-3430 |
Robyn F Graham, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 489 Pittsfield Lenox Rd, Lenox, MA 01240 Phone: 413-499-3430 Fax: 413-499-7029 |
Richard P Mole, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5 Walker St Ste 1, Lenox, MA 01240 Phone: 413-637-4700 Fax: 413-637-0366 |
Jeffrey Brown, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5 Walker St, Lenox Village Pharmacy, Lenox, MA 01240 Phone: 413-637-4700 Fax: 413-637-1411 |
News Archive
NOXXON Pharma AG (NOXXON), clinical-stage developer of L-RNA based scaffolds (SpiegelmersĀ®) that bind their targets conceptually similar to antibodies, announced today that the company was awarded a research grant from Germany's Federal Ministry of Education and Research (BMBF) under the ministry's small and medium enterprise innovation initiative ("KMU-Innovativ").
Cardiovascular disease pervades Appalachia, yet many Appalachians live far from any heart and vascular specialist. Follow-up doctor's visits in the weeks after cardiovascular surgery can involve hours-long drives down narrow, winding roads.
Treatment with omalizumab significantly decreases the number of colds in inner-city children with allergic asthma, researchers reported at a press conference today at the American Academy of Allergy, Asthma and Immunology 2016 Annual Meeting in Los Angeles. Omalizumab, sold under the brand name Xolair, is an injectable antibody that can be used to treat asthma cases not controlled by inhaled corticosteroids.
A pair of Chicago Sun-Times stories outline new research findings regarding hospice care. Meanwhile, an Arizona lawmaker pushes to restore hospice care to the category of Medicaid-covered services, arguing that the care is not only better, but more cost-effective.
› Verified 3 days ago